Hepatitis B Vaccination Results Which dose is Sufficient for Immunosuppressive Patients? Single or Double?

Hepatitis B Vaccination Results Which dose is Sufficient for Immunosuppressive Patients? Single or Double?

Aim: Despite effective HBV vaccine and vaccination programs, Hepatitis B still causes nearly one million deaths annually, according to the World Health Organization. The immunization rates are high by hepatitis B vaccination especially in young healthy population. However, advanced age, comorbiditie...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Servet ÖZTÜRK, Merve KAÇAR EKER, Semra KAVAS, Onur ÇOLAK, Derya ÖZTÜRK ENGİN, Canan AĞALAR
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Galenos Yayincilik 2020-12-01
Σειρά:	Namık Kemal Tıp Dergisi
Θέματα:	hepatitis b vaccine high dose response immunosuppression biological agent
Διαθέσιμο Online:	http://namikkemalmedj.com/archives/archive-detail/article-preview/hepatitis-b-vaccination-results-which-dose-is-suff/43285

Παρόμοια τεκμήρια

The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment
ανά: Servet ÖZTÜRK, κ.ά.
Έκδοση: (2021-12-01)

Hepatitis E virus immunosuppressed animal models
ανά: Kush Kumar Yadav, κ.ά.
Έκδοση: (2024-09-01)

Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy
ανά: Hae Lim Lee, κ.ά.
Έκδοση: (2017-11-01)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
ανά: Venessa Pattullo
Έκδοση: (2016-06-01)

The use of immunosuppression in autoimmune hepatitis: A current literature review
ανά: Angela Cropley, κ.ά.
Έκδοση: (2017-03-01)

Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy
ανά: Gabriel Pacífico Seabra Nunes, κ.ά.
Έκδοση: (2019-03-01)

A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma
ανά: Tae Won Lim, κ.ά.
Έκδοση: (2014-12-01)

Potential immunosuppressive and anti-inflammatory activity of aqueous extract of Mangifera indica
ανά: Amit Gupta, κ.ά.
Έκδοση: (2016-04-01)

Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL
ανά: Zhengping Li, κ.ά.
Έκδοση: (2024-06-01)

Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
ανά: Marco Masetti, κ.ά.
Έκδοση: (2023-03-01)

Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients
ανά: Yan-Ni Li, κ.ά.
Έκδοση: (2016-01-01)

Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination
ανά: Mohammad Minakari, κ.ά.
Έκδοση: (2014-01-01)

Are Patients with Different Rheumatologic Diseases Under Immunosuppressive Therapies Adequately Screened and Protected Against Viral Hepatitis?
ανά: Gökçe KENAR, κ.ά.
Έκδοση: (2022-06-01)

Hepatitis B virus infection in patients presenting for immunosuppressive cancer therapy with and without underlying HIV infection
ανά: Malowane H. Ngoato, κ.ά.
Έκδοση: (2023-09-01)

The effects of immunosuppressive agents on inflammatory response in septic rats
ανά: Filiz Ali, κ.ά.
Έκδοση: (2010-12-01)

Herbal Medicines for Immunosuppression
ανά: Zahra Amirghofran
Έκδοση: (2012-06-01)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
ανά: Jong Man Kim, κ.ά.
Έκδοση: (2016-09-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
ανά: John Benest, κ.ά.
Έκδοση: (2020-03-01)

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: a modern view of the method (review of literature)
ανά: A. Yu. Polushin, κ.ά.
Έκδοση: (2022-05-01)

Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods
ανά: Edvin Brusač, κ.ά.
Έκδοση: (2019-09-01)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
ανά: Yuzhuo Zhang, κ.ά.
Έκδοση: (2022-12-01)

Interest in Immunosuppression Withdrawal among Liver Transplant and Autoimmune Hepatitis Patients
ανά: Eden Sharabi, κ.ά.
Έκδοση: (2021-04-01)

The ongoing unnecessary debate regarding the risk factors for osteoradionecrosis of the jaw: Prescription dose versus mandibular doses
ανά: Erkan Topkan, κ.ά.
Έκδοση: (2024-06-01)

Immunosuppressants: implications in Orthodontics
ανά: Rogério Lacerda dos Santos, κ.ά.
Έκδοση: (2012-04-01)

Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study)Research in context
ανά: Julian Stumpf, κ.ά.
Έκδοση: (2024-01-01)

Image quality and pathology assessment in CT Urography: when is the low-dose series sufficient?
ανά: Bharti Kataria, κ.ά.
Έκδοση: (2019-08-01)

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
ανά: João Marcello de Araujo-Neto, κ.ά.
Έκδοση: (2022-08-01)

Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID‐19 outbreak?
ανά: Saeedeh Farajzadeh, κ.ά.
Έκδοση: (2021-05-01)

Retrospective Evaluation of the Treatment Results of Patients with Chronic Hepatitis B and C Infections
ανά: Servet Öztürk, κ.ά.
Έκδοση: (2020-02-01)

Pharmacokinetics of immunosuppressive agents during hemoperfusion in a sheep model
ανά: Bettina Leber, κ.ά.
Έκδοση: (2023-10-01)

Vaccination in the Era of Immunosuppression
ανά: Fatima Alnaimat, κ.ά.
Έκδοση: (2023-09-01)

Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus
ανά: Emily A. Bosselmann, κ.ά.
Έκδοση: (2023-04-01)

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
ανά: Yan Tie, κ.ά.
Έκδοση: (2022-05-01)

Orthognathic surgery in the immunosuppressed post-organ transplant individual
ανά: Ian Jenkyn, κ.ά.
Έκδοση: (2021-04-01)

A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan
ανά: Yuki Yanagisawa, κ.ά.
Έκδοση: (2024-04-01)

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
ανά: Romanee Chaiwarith, κ.ά.
Έκδοση: (2019-11-01)

New immunosuppressive agents in pediatric transplantation
ανά: Christina Nguyen, κ.ά.
Έκδοση: (2014-01-01)

A photodistributed eruption in an immunosuppressed patient
ανά: Alysha Colon, MD, κ.ά.
Έκδοση: (2021-09-01)

Immunosuppression in lung transplantation: Changing perspectives
ανά: Unmil Shah, κ.ά.
Έκδοση: (2021-01-01)

Low dose bitter leaf improves sperm quality disrupted in immunosuppressed Wistar rats: An experimental study
ανά: Risikat Eniola Kadir, κ.ά.
Έκδοση: (2020-03-01)